CiVentiChem is a premier Contract Development and Manufacturing Organization (CDMO) with over 30 years of experience serving the pharmaceutical and specialty chemical industries. We operate two facilities in India, specializing in medicinal chemistry, process chemistry, and the manufacturing of Regulatory Starting Materials (RSMs) and intermediates. Our team’s expertise allows us to support projects at every stage, from early drug discovery to full-scale commercial production. In 2019, we successfully sold our GMP kilo-lab in Cary, North Carolina, to Sterling Pharma, further focusing our efforts on expanding our global manufacturing capabilities. In 2024, we made significant investments to increase our production capacity, enabling us to manage programs ranging from gram-scale synthesis to multi-ton manufacturing. To better serve our U.S. clients, we maintain an office in Cary, North Carolina, which facilitates the seamless shipping and receiving of materials from India. CiVentiChem is committed to delivering simple solutions to complex chemistry challenges across all phases of drug development.